| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |